Month: May 2019

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

May 29, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $25 million financing with Vensana Capital as the lead investor.  Vensana was joined by existing investors including New Enterprise Associates (“NEA”), H.I.G. BioHealth Partners, and Quaker Partners.  The Company reported closure of …

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System® Read More »

Intact Vascular to Sponsor Post-Angioplasty Dissection Symposium at 2019 New Cardiovascular Horizons ConferencePresentations Highlight the Tack Endovascular System® for Focal Dissection Repair Device Following Balloon Angioplasty 

May 20, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured during a lunch symposium at the 2019 New Cardiovascular Horizons (NCVH) Conference, May 29th through 31st at The Roosevelt New Orleans in New Orleans, Louisiana. …

Intact Vascular to Sponsor Post-Angioplasty Dissection Symposium at 2019 New Cardiovascular Horizons ConferencePresentations Highlight the Tack Endovascular System® for Focal Dissection Repair Device Following Balloon Angioplasty  Read More »

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

First-of-its-kind study designed to demonstrate safety and efficacy of the Tack Endovascular System® in treating post-PTA dissections  November 6, 2018 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced at the 15th annual VIVA conference in Las Vegas that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial …

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial Read More »

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 6, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the first commercial use of its Tack Endovascular System in multiple sites across the United States. Recently FDA-approved for above-the-knee interventions, the first-of-its-kind dissection repair device is implanted post-angioplasty to resolve dissections in …

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use Read More »

Scroll to Top
Intact Vascular uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this.